{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T02:21:53Z","timestamp":1770603713192,"version":"3.49.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4994","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T22:04:27Z","timestamp":1447538667000},"page":"2893-2898","source":"Crossref","is-referenced-by-count":5,"title":["Light-Chain Deposition Disease Successfully Treated with Bortezomib in an Elderly Patient: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"54","author":[{"given":"Yukihiro","family":"Wada","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Iyoda","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Arai-Nunota","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseri","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Tomita","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Yamaguchi's Pathology Laboratory, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Randall RE, Williamson WC Jr, Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med 69: 703-710, 1976.","DOI":"10.1016\/0002-9343(76)90440-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112: 455-464, 1990.","DOI":"10.7326\/0003-4819-76-3-112-6-455"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light and heavy-chain deposition diseases. Hematol Oncol Clin North Am 13: 1235-1248, 1999.","DOI":"10.1016\/S0889-8588(05)70123-4"},{"key":"4","unstructured":"4. McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW. Plasma cell neoplasms In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer, Lyon, 2008: 200-213."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jimenez-Zepeda VH. Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol 34: 347-355, 2012.","DOI":"10.1111\/j.1751-553X.2012.01419.x"},{"key":"6","unstructured":"6. Ronco PM, Alyanakian MA, Mougenot B, Aucouturier P. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol 12: 1558-1565, 2001."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Royer B, Arnulf B, Martinez F, et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int 65: 642-648, 2004.","DOI":"10.1111\/j.1523-1755.2004.00427.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lorenz EC, Gertz MA, Fervenza FC, et al. Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrol Dial Transplant 23: 2052-2057, 2008.","DOI":"10.1093\/ndt\/gfm918"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Richardson PG, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. New Engl J Med 352: 2487-2498, 2005.","DOI":"10.1056\/NEJMoa043445"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Bortezomib: proteasome inhibition as an effective anticancer therapy. Annu Rev Med 57: 33-47, 2006.","DOI":"10.1146\/annurev.med.57.042905.122625"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Minarik J, Scudla V, Tichy T, et al. Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement. Leuk Lymphoma 53: 330-331, 2012.","DOI":"10.3109\/10428194.2011.619610"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadijkonstatinou V, Dimopoulus M. Treatment of light chain deposition disease with bortezomib and dexamethasone. Hematologica 94: 300-302, 2009.","DOI":"10.3324\/haematol.13548"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jimenez-Zepeda VH, Trudel S, Winter A, Reece DE, Chen C, Kukreti V. Autologous stem cell transplant for light chain deposition disease: incorporating bortezomib to the induction therapy. Am J Hematol 87: 822-823, 2012.","DOI":"10.1002\/ajh.23235"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Larsen CP, Bell JM, Harris AA, Messias NC, Wang YH, Walker PD. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation. Mod Pathol 24: 1462-1469, 2011.","DOI":"10.1038\/modpathol.2011.104"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 79: 319-328, 2005.","DOI":"10.1002\/ajh.20381"},{"key":"16","unstructured":"16. Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 12: 1482-1492, 2001."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nasr SH, Valeri AM, Cornell LD, et al. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol 7: 231-239, 2012.","DOI":"10.2215\/CJN.08640811"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pozzi C, D'Amico M, Fogazzi GB, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 42: 1154-1163, 2003.","DOI":"10.1053\/j.ajkd.2003.08.040"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tovar N, Cibeira MT, Rosiñol L, et al. Bortezomib\/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease. Eur J Haematol 89: 340-344, 2012.","DOI":"10.1111\/j.1600-0609.2012.01821.x"},{"key":"20","unstructured":"20. Said S, J Cooper C, C Nwosu A, E Bilbao J, T Hernandez G. Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature. J Nephropathol 3: 63-68, 2014."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gharwan H, Truica CI. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure. Med Oncol 29: 1197-1201, 2012.","DOI":"10.1007\/s12032-011-9938-4"},{"key":"22","unstructured":"22. Moiz A, Javed T, Garces J, Staffeld-Coit C, Paueksakon P. Late recurrence of light chain deposition disease after kidney transplantation treated with bortezomib: a case report. Ochsner J 14: 445-459, 2014."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jimenez-Zepeda VH, Vajpeyi R, John R, Trudel S. Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation. Int J Hematol 96: 125-131, 2012.","DOI":"10.1007\/s12185-012-1090-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kaposztas Z, Kahan BD, Katz SM, Van Buren CT, Cherem L. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report. Transplant Proc 41: 4407-4410, 2009.","DOI":"10.1016\/j.transproceed.2009.10.005"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/22\/54_54.4994\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T15:15:03Z","timestamp":1567350903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/22\/54_54.4994\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4994","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}